BRIDION
These highlights do not include all the information needed to use BRIDION safely and effectively. See full prescribing information for BRIDION. BRIDION (sugammadex) Injection, for intravenous use Initial U.S. Approval: 2015
Approved
Approval ID
5171d883-fe8f-482c-97ab-40b00975b64a
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 1, 2023
Manufacturers
FDA
Merck Sharp & Dohme LLC
DUNS: 118446553
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
sugammadex
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0006-5423
Application NumberNDA022225
Product Classification
M
Marketing Category
C73594
G
Generic Name
sugammadex
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 17, 2022
FDA Product Classification
INGREDIENTS (4)
SUGAMMADEX SODIUMActive
Quantity: 100 mg in 1 mL
Code: ERJ6X2MXV7
Classification: ACTIM
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
sugammadex
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0006-5425
Application NumberNDA022225
Product Classification
M
Marketing Category
C73594
G
Generic Name
sugammadex
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 17, 2022
FDA Product Classification
INGREDIENTS (4)
SUGAMMADEX SODIUMActive
Quantity: 100 mg in 1 mL
Code: ERJ6X2MXV7
Classification: ACTIM
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT